As of 2026-05-27, the Intrinsic Value of Bioqual Inc (BIOQ) is 22.51 USD. This BIOQ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 35.01 USD, the upside of Bioqual Inc is -35.70%.
The range of the Intrinsic Value is 18.57 - 35.93 USD
Based on its market price of 35.01 USD and our intrinsic valuation, Bioqual Inc (BIOQ) is overvalued by 35.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 18.57 - 35.93 | 22.51 | -35.7% |
| DCF (Growth 10y) | 39.75 - 105.79 | 54.77 | 56.4% |
| DCF (EBITDA 5y) | 46.01 - 54.12 | 49.96 | 42.7% |
| DCF (EBITDA 10y) | 59.32 - 73.09 | 65.89 | 88.2% |
| Fair Value | 2.55 - 2.55 | 2.55 | -92.73% |
| P/E | 34.99 - 34.99 | 34.99 | -0.1% |
| EV/EBITDA | 47.29 - 60.12 | 53.15 | 51.8% |
| EPV | (2.95) - (7.18) | (5.07) | -114.5% |
| DDM - Stable | 5.60 - 27.29 | 16.45 | -53.0% |
| DDM - Multi | 22.03 - 85.13 | 35.21 | 0.6% |
| Market Cap (mil) | 31.16 |
| Beta | -0.18 |
| Outstanding shares (mil) | 0.89 |
| Enterprise Value (mil) | 20.82 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.02% |
| Cost of Debt | 5.00% |
| WACC | 4.99% |